- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Actinium Pharmaceuticals Inc (ATNM)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.360
1.530
52 wk Range
0.735
1.720
ATNM Technical Analysis
A summary for the Actinium Pharmaceuticals Inc share. Signals range from Strong Buy, Buy, Neutral, Sell to Strong Sell. It also offers detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and Buy, Sell, Overbought, Oversold or Neutral signals of common chart indicators (including RSI, MACD and CCI). Additionally, the page contains pivot points for Standard, Fibonacci and Camarilla, amongst others. All ATNM share technical studies are available in select time frames.
Summary:Sell
| Moving Averages: | Neutral | Buy: (6) | Sell: (6) |
| Technical Indicators: | Strong Sell | Buy: (0) | Sell: (8) |
Technical Indicators
Summary: Strong SellBuy: 0Neutral: 0Sell: 8
Oct 26, 2026 20:00 GMT
Name | Value | Action | ||
|---|---|---|---|---|
| RSI(14) | 40.209 | Sell | ||
| STOCH(9,6) | 7.698 | Oversold | ||
| STOCHRSI(14) | 1.247 | Oversold | ||
| MACD(12,26) | -0.001 | Sell | ||
| ADX(14) | 25.977 | Sell | ||
| Williams %R | -96.154 | Oversold | ||
| CCI(14) | -98.1272 | Sell | ||
| ATR(14) | 0.0500 | Less Volatility | ||
| Highs/Lows(14) | -0.1200 | Sell | ||
| Ultimate Oscillator | 44.956 | Sell | ||
| ROC | -13.208 | Sell | ||
| Bull/Bear Power(13) | -0.1039 | Sell | ||
Moving Averages
Summary: NeutralBuy: 6Sell: 6
Oct 26, 2026 20:00 GMT
Name | Simple | Exponential | |||
|---|---|---|---|---|---|
| MA5 | 1.390 Sell | | 1.399 Sell | | |
| MA10 | 1.436 Sell | | 1.426 Sell | | |
| MA20 | 1.489 Sell | | 1.442 Sell | | |
| MA50 | 1.380 Buy | | 1.377 Buy | | |
| MA100 | 1.218 Buy | | 1.292 Buy | | |
| MA200 | 1.201 Buy | | 1.217 Buy | | |
Pivot Points
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 1.388 | 1.392 | 1.393 | 1.397 | 1.398 | 1.402 | 1.403 |
| Fibonacci | 1.392 | 1.394 | 1.395 | 1.397 | 1.399 | 1.400 | 1.402 |
| Camarilla | 1.394 | 1.394 | 1.395 | 1.397 | 1.395 | 1.396 | 1.396 |
| Woodie's | 1.388 | 1.391 | 1.393 | 1.396 | 1.398 | 1.401 | 1.402 |
| DeMark's | - | - | 1.393 | 1.396 | 1.398 | - | - |
FAQ
From a Technical Analysis Perspective, Is Actinium Pharmaceuticals a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Do the Moving Averages for ATNM Currently Stand?
The moving averages for Actinium Pharmaceuticals show a Buy outlook, considering moving averages ranging from MA5 to MA200, with 10 Buy signals and 2 Sell signals.
What Is the Current Status of the Technical Indicators for Actinium Pharmaceuticals?
The technical indicators for Actinium Pharmaceuticals are in a Strong Buy position based on daily analysis, with 10 signals on buy indicators and 0 sell signals.
What Is ATNM's 14-Day RSI?
The current Relative Strength Index (RSI) of ATNM over the 14-day period is 40.209, which suggests that the stock is a Sell.
What Is ATNM's MACD?
ATNM's MACD is -0.001, which suggests that the stock is a Sell.
What Is ATNM's 5-Day Moving Average?
ATNM's 5-day moving average is 1.390, suggesting that the stock is a Sell.
What Is ATNM's 50-Day Moving Average?
ATNM's 50-day moving average is 1.380, suggesting that the stock is a Buy.
What Is ATNM's 200-Day Moving Average?
ATNM's 200-day moving average is 1.201, suggesting that the stock is a Buy.
What Is the Fibonacci Pivot Point Performance Value for ATNM?
The Fibonacci pivot point performance value for ATNM is 1.397.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.